The country which kicked off the entire enchilada on the medical efficacy front is now faced with a dilemma as its own regulations change – export cannabis to a world in need for profit or supply all Israeli patients first?
Finding new capital investment will become more difficult. While we can expect new markets coming online, we can also expect more regulations as well as considerable M&A activity and consolidation.
The USDA released guidelines for hemp testing, but questions remain for the future of proper quality and safety guidelines.
With a mission to support local farmers in the growing hemp industry, Harvest Connect wants to make Georgia a leader in the hemp and CBD market.
LeafCann is set to begin construction on an AU$50 million cultivation and processing center.
For all of the early enthusiasm, the Danish market gets bogged down in the same issues plaguing the rest of Europe.
In late November, the FDA issued 15 warning letters to CBD companies and published a fact sheet detailing their safety concerns for CBD products. The FDA says they cannot deem CBD to be generally recognized as safe and that they will not tolerate making unsubstantiated health claims, marketing to children, using CBD as an ingredient in foods and marketing it as a dietary supplement.
Nevada regulators suspended the license for Certified Ag Labs after investigators accused the lab of pumping up THC numbers. A spokesperson for the lab fired back at regulators, calling the accusations “baseless and appalling.”
How are hemp and CBD regulated? How does the FDA treat CBD as a drug or as a food ingredient? Nathan Libbey takes a stab at those questions and more in this piece.
Hexo reported to Canadian regulatory authorities that they acquired unlicensed spaces as part of a Newstrike Brands buyout.